Study guide
5.2 Vasoactives, Sedation & Emergency Medications
ARRT Cardiac-Interventional Radiography CI
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Structured Education & Clinical Experience 1.3 Content Outline & Study Plan
2 Patient Communication & Assessment
2.1 Pre-, Intra-, and Postprocedure Communication 2.2 History, Allergies, Medications & Team Communication 2.3 Screening, NPO, Education & Consent
3 Positioning, Access Assessment & Labs
3.1 Positioning & Vascular Access Assessment 3.2 Chemistry & Hematology Labs 3.3 Coagulation Studies & Arterial Blood Gas
4 Monitoring, Documentation & Contrast
4.1 Physiologic Monitoring in the Cath Lab 4.2 Support Equipment & Procedure Documentation 4.3 Contrast Agents, Indications & Contraindications
5 Medications & Sterile Technique
5.1 Anticoagulants, Antiplatelets & Thrombolytics 5.2 Vasoactives, Sedation & Emergency Medications 5.3 Asepsis, Sterile Technique & Hazardous Materials
6 Emergency Care
6.1 Contrast Reactions & Contrast-Induced Nephropathy 6.2 Cardiac Emergencies (MI, CHF, Arrhythmia, Tamponade, Shock) 6.3 Access-Site & Vascular Emergencies
7 Image Acquisition & Processing
7.1 Fluoroscopy Dose Rates & Pulse Modes 7.2 Digital Acquisition, Roadmapping & Projections 7.3 Post-Processing, Reconstruction & PACS
8 Injectors, Intravascular Imaging & Radiation Protection
8.1 Automatic Pressure Injectors 8.2 Ultrasound, IVUS, OCT & ICE Equipment 8.3 Patient Radiation Protection 8.4 Personnel ALARA, Monitoring & QC
9 Diagnostic Foundations
9.1 Cardiac Anatomy & Pathophysiology 9.2 Right & Left Heart Hemodynamics 9.3 Coronary Angiography, Dominance & Projections
10 Additional Diagnostic Imaging
10.1 Graft, Pulmonary, Aortic & Ventricular Angiography 10.2 ICE, Intravascular Imaging & Endomyocardial Biopsy 10.3 Flow Reserve (FFR, iFR, RFR)
11 Access Angiography & Hemodynamic Calculations
11.1 Peripheral & Access-Site Angiography 11.2 Stroke Volume & Cardiac Output (Fick, Thermodilution, Angiographic) 11.3 Valve Area (Gorlin, Hakki) & Shunt Calculations
12 Electrophysiology
12.1 Arrhythmia Detection & Cardioversion 12.2 Ablation for AF, Atrial Flutter & VT 12.3 Permanent, Temporary, Leadless & Biventricular Pacemakers 12.4 ICD Insertion & Lead Extraction
13 Access, Equipment & Closure
13.1 Access Methods & Ultrasound Guidance 13.2 Sheaths, Catheters, Guidewires & Manifold 13.3 Closure Devices, Pressure & Dressings
14 Suite Design & Procedure Complications
14.1 Interventional Suite & Hybrid OR 14.2 Recognition & Treatment of Procedure Complications
15 Percutaneous Intervention Basics
15.1 Coronary & Peripheral Angioplasty 15.2 Coronary & Peripheral Stent Placement 15.3 Coronary & Peripheral Atherectomy
16 Adjunctive PCI & Retrieval
16.1 Mechanical, Pharmacologic & Aspiration Thrombectomy 16.2 IVC Filters & Foreign-Body Retrieval 16.3 Pericardiocentesis
17 Mechanical Support & Advanced Devices
17.1 IABP & Catheter-Based Ventricular Assist Devices 17.2 ECMO, Intravascular Lithotripsy & Distal Embolic Protection
18 Structural Heart: Septal Defects & TAVR
18.1 PFO & ASD Closure 18.2 Ventricular Septal Defect Closure 18.3 TAVI/TAVR
19 Structural Heart: Valvuloplasty, TMVR & LAA
19.1 Valvuloplasty 19.2 Transcatheter Mitral Valve Repair 19.3 Left Atrial Appendage Closure
5.2 Vasoactives, Sedation & Emergency Medications
Key Takeaways Explain This Topic AI
Nitroglycerin (sublingual, IV, or intracoronary) treats spasm and ischemia but causes hypotension and is cautioned in right-ventricular infarct because those patients are preload-dependent.
Match constrictors to physiology: phenylephrine is pure alpha-1, norepinephrine is the common shock pressor, epinephrine is for arrest and anaphylaxis, and vasopressin appears in arrest algorithms conceptually.
Atropine treats vagal bradycardia; adenosine terminates SVT and produces FFR hyperemia; amiodarone or lidocaine treat VT/VF; beta blockers and diltiazem or verapamil are antihypertensives or antiarrhythmics with pump and block cautions.
Moderate sedation is typically midazolam plus fentanyl; naloxone reverses opioids, and flumazenil reverses benzodiazepines but can precipitate seizures.
ACLS is required for CI clinicals — the technologist's role is recognition, crash cart, defibrillator pads, and documentation, not a substitute for ACLS certification; sodium bicarbonate is not a routine arrest drug.
Last updated: August 2026
Vasoactives, Sedation, and Emergency Medications in the Cardiac Lab
ARRT Patient Care 1.E.1.c is vasoactives (constrictors, dilators) . 1.E.1.d is emergency medications . The rest of 1.E.1.e is analgesics, antiemetics, antihypertensives, antiarrhythmics, and moderate sedation . These drugs share one exam logic: they change blood pressure, rhythm, or consciousness in seconds, and the R.T.(CI) is the person watching the arterial line, the electrocardiogram, and the crash cart while the operator is looking at a coronary.
Advanced cardiovascular life support (ACLS) is required for CI clinical experience. This section teaches recognition and the technologist's role. It does not replace an ACLS card, and it does not invent milligram tables as if ARRT published them. Typical teaching doses below are labeled as such.
Quick Answer: Nitroglycerin (SL/IV/IC) treats spasm and ischemia but drops blood pressure and is cautioned in right-ventricular (RV) infarct . Pressors are not interchangeable: phenylephrine is pure alpha-1, norepinephrine is a common shock pressor, epinephrine is for arrest and anaphylaxis. Atropine treats vagal bradycardia. Adenosine is for SVT and for fractional flow reserve (FFR) hyperemia. Amiodarone or lidocaine treat VT/VF. Moderate sedation is midazolam plus fentanyl ; flumazenil can seize. Sodium bicarbonate is not a routine arrest drug.
Dilators: nitroglycerin and nitroprusside
Nitroglycerin (NTG) is the everyday dilator. Sublingual tablets or spray treat ischemic chest pain before or during a case. Intravenous infusion treats ongoing ischemia or hypertensive urgency in the lab. Intracoronary boluses treat catheter-induced spasm, ostial spasm, and are a first move in slow flow or no-reflow when the operator asks. The action is venodilation (preload down) plus coronary dilation. Hypotension is the reaction you must catch — look at the arterial line before you hand the syringe.
RV infarct , usually an inferior STEMI with right-ventricular involvement, is the classic caution. These patients are preload-dependent . NTG can drop blood pressure precipitously. If the operator is wiring a right coronary and the systolic pressure is already 80 mm Hg, do not independently push sublingual NTG because the patient reports chest pressure.
Nitroprusside is a potent arterial dilator used for afterload reduction (hypertensive crisis, acute heart-failure afterload dump) and sometimes intracoronary for no-reflow. Cyanide toxicity is a prolonged-infusion issue, not a single intracoronary dose issue. Immediate hypotension is the intra-case risk. Have a pressor plan before a nitroprusside infusion runs away.
Constrictors: phenylephrine, norepinephrine, epinephrine, dopamine, vasopressin
Match the drug to the physiology; do not treat “pressor” as one bottle.
Phenylephrine is a pure alpha-1 agonist. It raises systemic vascular resistance. It is useful for vasodilatory hypotension (sedation-related, NTG-related) when contractility is intact. Reflex bradycardia can appear. Typical teaching is a dilute intravenous bolus the circulating registered nurse draws; you keep the arterial waveform visible.
Norepinephrine combines alpha constriction with some beta-1 support. It is a common first-line vasopressor for shock with low vascular resistance. It produces less reflex bradycardia than phenylephrine. Extravasation can injure tissue — know the IV site.
Epinephrine is alpha plus beta. Use it for cardiac arrest , anaphylaxis , and profound hypotension. It raises heart rate and contractility as well as vascular resistance. In the lab it also appears as intracoronary epinephrine in some no-reflow algorithms — that is a physician-directed decision, not a circulating guess.
Dopamine is historically taught as dose-dependent (low “renal,” medium inotropic, high vasopressor). Modern shock algorithms have de-emphasized it; ARRT may still list it. Higher teaching doses are constricting and arrhythmogenic.
Vasopressin appears in arrest algorithms conceptually as a non-adrenergic vasopressor. Know that it lives on the crash cart and that it is not a coronary dilator. Do not reach for vasopressin to treat catheter spasm.
Emergency and antiarrhythmic core: atropine, adenosine, amiodarone, lidocaine
Atropine treats vagal reactions and symptomatic bradycardia — sheath insertion, contrast into the right coronary, or a full bladder. Typical ACLS teaching is 0.5–1 mg IV , repeatable to the algorithm ceiling. Atropine will not fix a wide, dying rhythm that needs pacing or epinephrine. Announce the rate and the arterial pressure when you call for it.
Adenosine has two lab jobs, and mixing them up is an exam trap. (1) Supraventricular tachycardia (SVT) — brief AV nodal block; typical teaching 6 mg rapid IV then 12 mg , with a flush, crash cart nearby. A few seconds of asystole or pause can be expected. (2) FFR hyperemia — typically an intravenous infusion (common teaching 140 mcg/kg/min ) or operator-directed intracoronary boluses so the coronary is maximally dilated. Warn the patient about chest pressure and flushing. FFR adenosine is not “the patient is in SVT.”
Amiodarone and lidocaine treat ventricular tachycardia / ventricular fibrillation per ACLS. Amiodarone is a common antiarrhythmic after defibrillation and epinephrine in a shockable arrest; lidocaine is an acceptable alternative. Both can cause hypotension (amiodarone especially if pushed fast). Pads should already be on before you need them.
Beta blockers, calcium-channel blockers, antihypertensives
Beta blockers (metoprolol, esmolol) are anti-ischemic, rate-controlling, and antihypertensive. Contraindications in teaching lists: decompensated heart failure, marked bradycardia, high-grade AV block, active severe bronchospasm, and shock. Esmolol's short half-life is useful when you might need the effect to vanish.
Diltiazem and verapamil slow AV conduction for atrial fibrillation or flutter with rapid ventricular response and for some SVTs. They are negative inotropes — avoid in decompensated reduced-ejection-fraction failure and in irregular wide-complex rhythms that might be pre-excited. Intracoronary nicardipine or verapamil (sometimes diltiazem) treat coronary spasm and no-reflow . Watch the arterial pressure; intracoronary calcium-channel blockers can drop systemic pressure.
Other intravenous antihypertensives in the lab include nicardipine infusions, hydralazine, and the nitrates already named. Treat the number in context: a systolic of 90 mm Hg during right-coronary ischemia is not hypertension to treat, and a systolic of 210 mm Hg before large-bore access is.
Moderate sedation, analgesics, antiemetics, reversal
Most labs use midazolam (benzodiazepine) plus fentanyl (opioid) for moderate sedation . The CI technologist does not independently “give more sedation.” You watch respiratory rate, pulse oximetry, capnography if used, blood pressure, and whether the patient still responds . Fentanyl causes respiratory depression and, in overdose, rigidity. Midazolam causes respiratory depression and amnesia.
Naloxone reverses opioids. The patient may wake in pain with a catecholamine surge. Re-sedation can occur because naloxone may wear off first. Flumazenil reverses benzodiazepines. The exam trap is seizure risk , especially in chronic benzodiazepine users or mixed overdoses. Flumazenil is not a routine wake-up button after every uneventful case.
Ondansetron is the common antiemetic . It can prolong QT; it is still widely used. Vomiting under a sterile drape is an aspiration risk and a field-contamination event. Have a basin and suction ready before the first contrast run in a nauseated patient.
Sodium bicarbonate is not routine in undifferentiated arrest. Teaching indications that still appear: severe metabolic acidosis, hyperkalemia, and certain sodium-channel-blocker poisonings. Do not push amp after amp because the code is long.
ACLS in the cath lab: recognition and the tech's role
CI clinicals require ACLS. The exam still wants the technologist's job description:
Recognize — loss of the arterial waveform, ventricular fibrillation on the monitor, sudden unresponsiveness, agonal breathing.
Call it — loud, closed-loop: “No arterial waveform, VF on the monitor.”
Bring the crash cart , attach the defibrillator, and get pads on (or follow the sterile defibrillation plan your lab uses).
Defibrillate as directed; clear the table; know how the fluoro table locks and how the C-arm parks so compressions and shocks can happen.
Document drugs, joules, times, and rhythms.
If a stem asks who runs the ACLS algorithm, the ACLS-trained team does. If it asks who gets the pads and the cart, that is the CI technologist. Do not invent sequences that contradict a current ACLS card.
Pressor versus dilator versus antiarrhythmic
- Drug Bucket Typical lab job Safety point
- Phenylephrine Constrictor (alpha-1) Sedation or NTG hypotension with intact pump Reflex bradycardia
Norepinephrine Constrictor (alpha greater than beta) Shock / low SVR Watch the IV site; titrate to the arterial line
- Epinephrine Constrictor plus inotrope Arrest, anaphylaxis, some no-reflow Tachycardia and ischemia
- Dopamine Dose-variable pressor/inotrope Older shock pathways Arrhythmia at higher teaching doses
- Vasopressin Constrictor (arrest concept) Crash-cart vasopressor Not a coronary dilator
- Nitroglycerin Dilator Spasm and ischemia (SL/IV/IC) Hypotension; RV infarct caution
- Nitroprusside Dilator (arterial) Afterload, some no-reflow Immediate hypotension
- IC nicardipine / verapamil Dilator / calcium-channel blocker Spasm, no-reflow Systemic hypotension
- Atropine Emergency / vagolytic Vagal bradycardia Will not pace a dying wide complex
- Adenosine Antiarrhythmic / hyperemia SVT; FFR max hyperemia Brief pause expected; warn the patient
- Amiodarone / lidocaine Antiarrhythmic VT/VF Hypotension; pads already on
Metoprolol / esmolol Beta blocker Ischemia, rate, blood pressure Avoid shock, block, decompensated heart failure
Diltiazem / verapamil Calcium-channel antiarrhythmic AF/SVT rate control Negative inotrope; not for decompensated HFrEF
Scenario
During right-coronary PCI the patient yawns, the arterial line falls to 62/40, and the rate is 38. This is a vagal picture until proven otherwise. Atropine as ordered, fluids, legs up if the table allows, stop NTG, and tell the operator. It is not an epinephrine arrest yet, and it is not a reason to give more fentanyl. If the same patient had a clear RV infarct and a systolic of 80 mm Hg, NTG would be the wrong “chest-pain” reflex.
Exam traps
NTG in RV infarct.
Adenosine for FFR is hyperemia, not an SVT rescue by default.
Flumazenil and seizures.
Bicarbonate is not a routine arrest drug.